EUVIMEDEUVIMED entdecken
Crossref

A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia

Kaiqi Jia, Manlin Zeng, Xiaoyong Zheng, Haixiao Xie, Lihong Yang, Yaosheng Xie, Mingshan Wang

Hämostaseologie · 01.12.2023 · 43 (06) · 426-431

DOI: 10.1055/a-2116-8957 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hämostaseologie, erschienen am 01.12.2023. Verfasst von Kaiqi Jia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Afibrinogenemia, Hemostatics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Our study aimed to analyze the phenotype and genotype of a pedigree with inherited dysfibrinogenemia, and preliminarily elucidate the probable pathogenesis.

Methods

The one-stage clotting method was used to test the fibrinogen activity (FIB:C), whereas immunoturbidimetry was performed to quantify the fibrinogen antigen (FIB:Ag). Furthermore, DNA sequence analysis was conducted to confirm the site of mutation. Conservation analysis and protein model analysis were performed using online bioinformatics software.

Results

The FIB:C and FIB:Ag of the proband were 1.28 and 2.20 g/L, respectively. Gene analysis revealed a heterozygous c.293C > A (p.BβAla68Asp) mutation in FGB. Bioinformatics and modeling analysis suggested that the missense mutation could potentially have a deleterious effect on fibrinogen.

Conclusion

The BβAla68Asp mutation in exon 2 of FGB may account for the reduced FIB:C levels observed in the pedigree. To our knowledge, this point mutation is the first report in the world.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AfibrinogenemiaHemostaticsHumansFibrinogenGenotypeMutation, MissenseMutationPedigree

Substanzen

FibrinogenHemostatics

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
  • Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, Zhejiang, People's Republic of China.

Zitieren

APA

Jia, K., Zeng, M., Zheng, X., Xie, H., Yang, L., Xie, Y., & Wang, M. (2023). A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia. Hämostaseologie, 43(06), 426-431. https://doi.org/10.1055/a-2116-8957

Vancouver

Jia K, Zeng M, Zheng X, Xie H, Yang L, Xie Y, et al. A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia. Hämostaseologie. 2023;43(06):426-431. doi:10.1055/a-2116-8957

BibTeX
@article{Jia2023,
  author = {Jia, Kaiqi and Zeng, Manlin and Zheng, Xiaoyong and Xie, Haixiao and Yang, Lihong and Xie, Yaosheng and Wang, Mingshan},
  title = {A Novel Fibrinogen Mutation p.BβAla68Asp Causes an Inherited Dysfibrinogenemia},
  journal = {Hämostaseologie},
  year = {2023},
  volume = {43},
  number = {06},
  pages = {426--431},
  doi = {10.1055/a-2116-8957}
}
Kostenlos starten →